Cognito’s Alzheimer’s brainwave
Gamma frequency neuromodulation is the key to treating dementia, according to the MIT spinout.
Onduo takes its time
The Verily subsidiary has the luxury of patient backers. But hungrier rivals could steal a march.
Philips spends nearly $3bn to integrate Biotelemetry
The deal is a late entrant into 2020's top five mergers and acquisitions.
Prescription apps take off during lockdown
Digital therapeutics are going from strength to strength during the pandemic.
Can Omada do a Livongo?
Omada is better funded than its digital health rival Livongo, but can it achieve a similar valuation?
FDA tightens up digital health oversight
Software-enabled medical devices pose unique challenges to regulators, and the US agency is getting serious about meeting them.
Boehringer hopes schizophrenia apps will Click into place
Licensing deal could enable bundling of antipsychotics with management technology.
Teladoc bets $18.5bn that Covid-19 will change the world for good
The purchase of Livongo is the richest healthcare deal this year, but questions about reimbursement, competition and profitability remain.
